{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:31Z","timestamp":1790899231592,"version":"4.1.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/rlu.0b013e3182867b99","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T21:33:56Z","timestamp":1363988036000},"page":"1-7","source":"Crossref","is-referenced-by-count":46,"title":["Implication of Lymph Node Metastasis Detected on 18F-FDG PET\/CT for Surgical Planning in Patients With Peripheral Intrahepatic Cholangiocarcinoma"],"prefix":"10.1097","volume":"39","author":[{"given":"Tae Gyu","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Dong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Jeong","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Gol","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210204","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1245\/s10434-009-0631-1","article-title":"The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.","volume":"16","author":"Choi","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"R2-1-20210204","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.surg.2008.01.010","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.","volume":"143","author":"Seo","year":"2008","journal-title":"Surgery"},{"key":"R3-1-20210204","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers.","volume":"341","author":"De Groen","year":"1999","journal-title":"N Eng J Med"},{"key":"R4-1-20210204","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1148\/radiographics.22.1.g02ja15173","article-title":"Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings.","volume":"22","author":"Han","year":"2002","journal-title":"Radiographics"},{"key":"R5-1-20210204","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0002-9610(02)00853-X","article-title":"Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma.","volume":"183","author":"Kawarada","year":"2002","journal-title":"Am J Sur"},{"key":"R6-1-20210204","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00259-002-0852-z","article-title":"Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.","volume":"29","author":"Kato","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"R7-1-20210204","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF02988499","article-title":"From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology.","volume":"15","author":"Kubota","year":"2001","journal-title":"Ann Nucl Med"},{"key":"R8-1-20210204","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-003-1297-8","article-title":"Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.","volume":"30","author":"Kim","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-1-20210204","first-page":"333","article-title":"Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.","volume":"33","author":"Okazumi","year":"1992","journal-title":"J Nucl Med"},{"key":"R10-1-20210204","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00004728-199209000-00003","article-title":"Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET.","volume":"16","author":"Messa","year":"1992","journal-title":"J Comput Assist Tomogr"},{"key":"R11-1-20210204","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2001.03888.x","article-title":"Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma.","volume":"96","author":"Shiomi","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R12-1-20210204","first-page":"60","article-title":"Clinical application of F-18 FDG PET in hepatocellular carcinoma.","volume":"42","author":"Oh","year":"2008","journal-title":"Nucl Med Mol Imaging"},{"key":"R13-1-20210204","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00535-006-1877-z","article-title":"Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.","volume":"41","author":"Miwa","year":"2006","journal-title":"J Gastroenterol"},{"key":"R14-1-20210204","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archsurg.1995.01430100051011","article-title":"Intrahepatic cholangiocarcinoma. Results of aggressive surgical management.","volume":"130","author":"Cherqui","year":"1995","journal-title":"Arch Surg"},{"key":"R15-1-20210204","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/msy.2000.104673","article-title":"Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma.","volume":"127","author":"Inoue","year":"2000","journal-title":"Surgery"},{"key":"R16-1-20210204","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2214\/ajr.172.1.9888743","article-title":"Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings.","volume":"172","author":"Feydy","year":"1999","journal-title":"Am J Roentgenol"},{"key":"R17-1-20210204","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1572-0241.2007.01710.x","article-title":"Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.","volume":"103","author":"Kim","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R18-1-20210204","first-page":"544","article-title":"Late recurrence after surgery for cholangiocarcinoma: implications for follow-up Hepatobiliary Pancreat Dis Int.","volume":"7","author":"Thomas","year":"2008","journal-title":""}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e3182867b99","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:29:08Z","timestamp":1621884548000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201401000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e3182867b99","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}